giancarlo parenti

Full Professor

Università degli Studi di Napoli Federico II

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Giancarlo Parenti is a Full Professor at Università degli Studi di Napoli Federico II, Italy. His research focuses on metabolic diseases, particularly Pompe disease, examining clinical pathways, immune responses, and therapeutic strategies. He has contributed significantly to understanding the efficacy of enzyme replacement therapies and the pathophysiology of hepatic glycogen storage diseases.

Articles (12)

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (12)

Wolfgang Löscher

Medical University of Innsbruck

AUSTRIA

View details

Hidde Huidekoper

Erasmus University Rotterdam

NETHERLANDS

View details

Esmeralda Martins

Assistant Professor of Pediatrics

Instituto de Ciências Biomédicas Abel Salazar

PORTUGAL

View details

Terry Derks

NETHERLANDS

View details

Jerome AUSSEIL

Université Toulouse III - Paul Sabatier

FRANCE

View details

Andrea BALLABIO

PROFESSOR

Baylor College of Medicine

UNITED STATES

View details

Agnes Sebok

Assistant Professor

University of Pecs

HUNGARY

View details

Annamaria Colao

ITALY

View details

Alessia Indrieri

Telethon Institute of Genetics and Medicine

ITALY

View details

Marco Spada

University of Turin

ITALY

View details

Gerlind Sulzenbacher

FRANCE

View details

Hani Kushlaf

Associate Professor of Neurology & Pathology

University of Cincinnati

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

giancarlo parenti

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Endocrine involvement in hepatic glycogen storage diseases

The European reference network for metabolic diseases (MetabERN) clinical pathway recommendations for Pompe disease (acid maltase deficiency, glycogen storage disease type II)

Effect of alglucosidase alfa dosage on survival and walking ability in patients with classic infantile Pompe disease

Immune responses to alglucosidase in infantile Pompe disease: recommendations from an Italian pediatric expert panel

Safety and efficacy of cipaglucosidase alfa plus miglustat versus alglucosidase alfa plus placebo in late-onset Pompe disease (PROPEL): an international, randomised, double-blind, parallel-group, phase 3 trial.

The rapidly evolving view of lysosomal storage diseases

Intracerebral gene therapy in 4 children with Sanfilippo B syndrome : 5.5 years follow-up results.

Carnitine is a pharmacological allosteric chaperone of the human lysosomal <i>α</i>-glucosidase.

Safety and efficacy of cipaglucosidase alfa plus miglustat versus alglucosidase alfa plus placebo in late-onset Pompe disease (PROPEL): an international, randomised, double-blind, parallel-group, phase 3 trial

Effect of alglucosidase alfa dosage on survival and walking ability in patients with classic infantile Pompe disease: a multicentre observational cohort study from the European Pompe Consortium.

Correction of oxidative stress enhances enzyme replacement therapy in Pompe disease.

An Overview of Hypoglycemia in Children Including a Comprehensive Practical Diagnostic Flowchart for Clinical Use

Collaborators (12)

Wolfgang Löscher

Hidde Huidekoper

Esmeralda Martins

Terry Derks

Jerome AUSSEIL

Andrea BALLABIO

Agnes Sebok

Annamaria Colao

Alessia Indrieri

Marco Spada

Gerlind Sulzenbacher

Hani Kushlaf

Make your next move.